Factors related to post-treatment relapse in chronic hepatitis B patients who lost HBeAg after lamivudine therapy.

@article{Byun2005FactorsRT,
  title={Factors related to post-treatment relapse in chronic hepatitis B patients who lost HBeAg after lamivudine therapy.},
  author={Kwan Soo Byun and Oh Sang Kwon and Ju Hyun Kim and Hyung Joon Yim and Yun Jung Chang and Jin Yong Kim and Jong Eun Yeon and Jong Jae Park and Jae Seon Kim and Young Tae Bak and Chang Hong Lee},
  journal={Journal of gastroenterology and hepatology},
  year={2005},
  volume={20 12},
  pages={1838-42}
}
BACKGROUND AND AIM It is uncertain if a patient's lamivudine response after HBeAg loss is durable. In Korean chronic hepatitis B patients, the relapse rate is high after termination of lamivudine therapy for patients with HBeAg loss. We evaluated the factors related to relapse in chronic hepatitis B patients with HBeAg loss after lamivudine therapy. METHODS A total of 132 chronic hepatitis B patients, who initially had HBeAg and did not have decompensated features, were analyzed in this study… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 11 extracted citations

Similar Papers

Loading similar papers…